Spring 2023 Hybrid-Seminar Series Mondays 1.00-2.00 pm (EST) Towne 225 / Raisler Lounge “For Zoom link, please contact <manu@seas.upenn.edu>”
BE
Calendar of Events
S
Sun
|
M
Mon
|
T
Tue
|
W
Wed
|
T
Thu
|
F
Fri
|
S
Sat
|
---|---|---|---|---|---|---|
0 events,
|
2 events,
-
-
Please save the date to join us for this annual distinguished lecture. The Joseph Bordogna Forum will foster conversation and debate regarding important issues at the nexus of technology and society. It will feature lectures and panel discussions on a wide range of contemporary issues that are central to engineering including diversity and inclusion, the […] |
1 event,
-
Attention BE Master's Students! We want your thoughts on the job search! Sign up for this upcoming focus group to give us your opinion on industries of interest, employers & recruiting events. Register now: http://tinyurl.com/bdzz8cna. Contact Lauren Kemp with any questions: laurem@seas.upenn.edu |
0 events,
|
2 events,
-
"The Future of Brain Interfacing" Brain interfacing holds immense promise, both for restoring lost sensory, motor or cognitive function and for the treatment of neurological and neuropsychiatric disorders. The promise is driving a great deal of interest in brain interfacing technologies -- from researchers, industry, investors, and the public -- yet the clinical impact of […]
-
Advances in the fields of tissue engineering and regenerative medicine require biomaterials that instruct, rather than simply permit, a desired cellular response. A major challenge to progress in our field is the complex organization of the tissues in our bodies, which are hierarchical, vary in space and time, and can differ person-to person. Prof. Harley’s […] |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
-
Spring 2023 Hybrid-Seminar Series Mondays 1.00-2.00 pm (EST) Towne 225 / Raisler Lounge “For Zoom link, please contact <manu@seas.upenn.edu>” |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
2 events,
-
Adoptive cell therapy (ACT) is a type of immunotherapy that involves the processing of blood from a donor to isolate immune cells (e.g. T cells) for genetic manipulation followed by reinfusion of the cells into patients. Specifically for CAR T cell therapy, genetic coding material (e.g. DNA, mRNA) is inserted into the T cells to […]
-
Spring 2023 Hybrid-Seminar Series Mondays 1.00-2.00 pm (EST) Towne 225 / Raisler Lounge “For Zoom link, please contact <manu@seas.upenn.edu>” |
1 event,
-
Attention BE Master’s Students! We want your thoughts on the job search! Sign up for this upcoming focus group to give us your opinion on industries of interest, employers & recruiting events. Register now: http://tinyurl.com/bdzz8cna. Contact Lauren Kemp with any questions: laurem@seas.upenn.edu |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
-
Spring 2023 Hybrid-Seminar Series Mondays 1.00-2.00 pm (EST) Towne 225 / Raisler Lounge “For Zoom link, please contact <manu@seas.upenn.edu>” |
1 event,
-
Many human health problems are associated with alteration of tissue mechanics and often require mechanical stimulation to promote the healing process. While it is now well established that the mechanics of the cellular microenvironment regulate various biological processes, most studies have focused only on the effect of stiffness, leaving other mechanical parameters such as viscoelasticity […] |
1 event,
-
The Department of Bioengineering at the University of Pennsylvania and Dr. Pablo Camara are pleased to announce the Doctoral Dissertation Defense of Rachael Aubin. Title: UNDERSTANDING THE CELLULAR AND GENE-REGULATORY MECHANISMS UNDERLYING THE MESENCHYMAL TRANSITION OF EPENDYMOMA TUMOR CELLS USING OMICS DATA Date: Wednesday, March 29 Time: 9:30am Location: Reunion Auditorium, John Morgan Building Zoom link: https://upenn.zoom.us/j/97229075338 The public […] |
1 event,
-
This seminar will be held in person only; snacks will be provided. Immunomodulatory therapies have advanced to clinical trials over the past decade for the treatment of a range of diseases and disorders, from cancer to diabetes to transplant rejection. However, the efficacy of these therapies remains limited, as challenges associated with off-target drug toxicity, […] |
0 events,
|
0 events,
|